Correlation Between OmniAb and AIM ImmunoTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OmniAb and AIM ImmunoTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OmniAb and AIM ImmunoTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OmniAb Inc and AIM ImmunoTech, you can compare the effects of market volatilities on OmniAb and AIM ImmunoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OmniAb with a short position of AIM ImmunoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of OmniAb and AIM ImmunoTech.

Diversification Opportunities for OmniAb and AIM ImmunoTech

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between OmniAb and AIM is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding OmniAb Inc and AIM ImmunoTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AIM ImmunoTech and OmniAb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OmniAb Inc are associated (or correlated) with AIM ImmunoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AIM ImmunoTech has no effect on the direction of OmniAb i.e., OmniAb and AIM ImmunoTech go up and down completely randomly.

Pair Corralation between OmniAb and AIM ImmunoTech

Given the investment horizon of 90 days OmniAb Inc is expected to generate 0.72 times more return on investment than AIM ImmunoTech. However, OmniAb Inc is 1.38 times less risky than AIM ImmunoTech. It trades about 0.05 of its potential returns per unit of risk. AIM ImmunoTech is currently generating about -0.14 per unit of risk. If you would invest  160.00  in OmniAb Inc on September 4, 2025 and sell it today you would earn a total of  11.00  from holding OmniAb Inc or generate 6.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

OmniAb Inc  vs.  AIM ImmunoTech

 Performance 
       Timeline  
OmniAb Inc 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in OmniAb Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile fundamental drivers, OmniAb may actually be approaching a critical reversion point that can send shares even higher in January 2026.
AIM ImmunoTech 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in January 2026. The recent disarray may also be a sign of long period up-swing for the firm investors.

OmniAb and AIM ImmunoTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OmniAb and AIM ImmunoTech

The main advantage of trading using opposite OmniAb and AIM ImmunoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OmniAb position performs unexpectedly, AIM ImmunoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AIM ImmunoTech will offset losses from the drop in AIM ImmunoTech's long position.
The idea behind OmniAb Inc and AIM ImmunoTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital